Anker SD - Search Results

1

Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial.

Böhm M, Butler J, Krawczyk M, Mahfoud F, Haring B, Filippatos G, Ferreira JP, Pocock SJ, Brueckmann M, Ofstad AP, Schüler E, Wanner C, Verma S, Packer M, Anker SD; EMPEROR-Preserved Trial Committees and Investigators. Böhm M, et al. Among authors: anker sd. Eur J Heart Fail. 2023 Aug;25(8):1375-1383. doi: 10.1002/ejhf.2922. Epub 2023 Jun 27. Eur J Heart Fail. 2023. PMID: 37278451 Free article. Clinical Trial.

2

The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.

Anker SD, Swan JW, Volterrani M, Chua TP, Clark AL, Poole-Wilson PA, Coats AJ. Anker SD, et al. Eur Heart J. 1997 Feb;18(2):259-69. doi: 10.1093/oxfordjournals.eurheartj.a015229. Eur Heart J. 1997. PMID: 9043843

3

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.

Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, Stevenson JC, Coats AJ. Leyva F, et al. Eur Heart J. 1997 May;18(5):858-65. doi: 10.1093/oxfordjournals.eurheartj.a015352. Eur Heart J. 1997. PMID: 9152657

4

Hyperleptinaemia in chronic heart failure. Relationships with insulin.

Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ. Leyva F, et al. Among authors: anker sd. Eur Heart J. 1998 Oct;19(10):1547-51. doi: 10.1053/euhj.1998.1045. Eur Heart J. 1998. PMID: 9820994

5

Uric acid in chronic heart failure: a marker of chronic inflammation.

Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, Poole-Wilson PA, Coats AJ. Leyva F, et al. Among authors: anker sd. Eur Heart J. 1998 Dec;19(12):1814-22. doi: 10.1053/euhj.1998.1188. Eur Heart J. 1998. PMID: 9886724

6

The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.

Ponikowski P, Piepoli M, Chua TP, Banasiak W, Francis D, Anker SD, Coats AJ. Ponikowski P, et al. Among authors: anker sd. Eur Heart J. 1999 Nov;20(22):1667-75. doi: 10.1053/euhj.1999.1525. Eur Heart J. 1999. PMID: 10543930

7

Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.

Florea VG, Henein MY, Anker SD, Francis DP, Chambers JS, Ponikowski P, Coats AJ. Florea VG, et al. Among authors: anker sd. Eur Heart J. 2000 Jan;21(2):146-53. doi: 10.1053/euhj.2000.1737. Eur Heart J. 2000. PMID: 10637088

8

Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.

Crosato M, Steinborn W, Anker SD. Crosato M, et al. Among authors: anker sd. Heart Fail Monit. 2003;4(1):2-6. Heart Fail Monit. 2003. PMID: 12808478 Review.

9

Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.

Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Sharma R, et al. Among authors: anker sd. Eur Heart J. 2004 Jun;25(12):1021-8. doi: 10.1016/j.ehj.2004.04.023. Eur Heart J. 2004. PMID: 15191772 Clinical Trial.

10

B-type natriuretic peptide serum levels in acute heart failure.

Filippatos GS, Anker SD, Kardaras F. Filippatos GS, et al. Among authors: anker sd. Eur Heart J. 2004 Jun;25(12):1085; author reply 1085-6. doi: 10.1016/j.ehj.2004.03.027. Eur Heart J. 2004. PMID: 15191781 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,277 results

Search Page